Dyadic International, Inc. (DYAI)
NASDAQ: DYAI · Real-Time Price · USD
1.420
-0.070 (-4.70%)
Nov 21, 2024, 12:45 PM EST - Market open

Dyadic International Revenue

Dyadic International had revenue of $1.96M in the quarter ending September 30, 2024, with 393.00% growth. This brings the company's revenue in the last twelve months to $3.36M, up 13.82% year-over-year. In the year 2023, Dyadic International had annual revenue of $2.90M, down -1.07%.

Revenue (ttm)
$3.36M
Revenue Growth
+13.82%
P/S Ratio
12.90
Revenue / Employee
$480,650
Employees
7
Market Cap
42.02M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.90M-31.50K-1.07%
Dec 31, 20222.93M526.47K21.90%
Dec 31, 20212.40M801.91K50.06%
Dec 31, 20201.60M-79.16K-4.71%
Dec 31, 20191.68M385.63K29.77%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SHL Telemedicine 55.94M
Rapid Micro Biosystems 26.17M
Affimed 6.29M
Serina Therapeutics 3.16M
OncoCyte 709.00K
CollPlant Biotechnologies 689.00K
Actinium Pharmaceuticals 81.00K
Revenue Rankings